In conclusion, we identified novel compound heterozygous mutations in TYK2 associated with primary immunodeficiency characterized by a rare type of EBV-associated B-cell lymphoma and T-cell lymphopenia. This evidence concerns the gene TYK2 and B-cell non-Hodgkin lymphoma.